PortfoliosLab logoPortfoliosLab logo
VST vs. SMMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VST vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vistra Corp. (VST) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VST achieves a -8.82% return, which is significantly higher than SMMT's -19.33% return.


VST

1D
-1.25%
1M
-0.56%
YTD
-8.82%
6M
-11.33%
1Y
-14.96%
3Y*
83.12%
5Y*
54.75%
10Y*

SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VST vs. SMMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VST
Vistra Corp.
-8.82%17.66%261.52%70.73%5.08%19.57%-11.87%2.46%24.95%18.19%
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%

Correlation

The correlation between VST and SMMT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Oct 4, 2016

0.07

Fundamentals

EPS

VST:

$8.60

SMMT:

-$1.60

Total Revenue (TTM)

VST:

$17.20B

SMMT:

$0.00

Gross Profit (TTM)

VST:

$1.12B

SMMT:

-$83.36K

EBITDA (TTM)

VST:

$4.34B

SMMT:

-$738.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VST vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VST
VST Risk / Return Rank: 2929
Overall Rank
VST Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
VST Sortino Ratio Rank: 2828
Sortino Ratio Rank
VST Omega Ratio Rank: 2828
Omega Ratio Rank
VST Calmar Ratio Rank: 2929
Calmar Ratio Rank
VST Martin Ratio Rank: 2828
Martin Ratio Rank

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VST vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vistra Corp. (VST) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VSTSMMTDifference
Sharpe ratioReturn per unit of total volatility

+0.11

Sortino ratioReturn per unit of downside risk

+0.02

Omega ratioGain probability vs. loss probability

0.98

0.98

0.00

Calmar ratioReturn relative to maximum drawdown

-0.39

-0.60

+0.20

Martin ratioReturn relative to average drawdown

-0.74

-0.92

+0.18

VST vs. SMMT - Sharpe Ratio Comparison

The current VST Sharpe Ratio is -0.31, which is comparable to the SMMT Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of VST and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VSTSMMTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.31

-0.42

+0.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.15

0.08

+1.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.71

0.02

+0.69

Drawdowns

VST vs. SMMT - Drawdown Comparison

The maximum VST drawdown since its inception was -53.32%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for VST and SMMT.


Loading charts...

Drawdown Indicators


VSTSMMTDifference

Max Drawdown

Largest peak-to-trough decline

-53.32%

-95.75%

+42.43%

Max Drawdown (1Y)

Largest decline over 1 year

-38.01%

-52.76%

+14.75%

Max Drawdown (3Y)

Largest decline over 3 years

-48.80%

-62.26%

+13.46%

Max Drawdown (5Y)

Largest decline over 5 years

-48.80%

-91.78%

+42.98%

Max Drawdown (10Y)

Largest decline over 10 years

-95.75%

Current Drawdown

Current decline from peak

-32.40%

-61.55%

+29.15%

Average Drawdown

Average peak-to-trough decline

-13.69%

-57.64%

+43.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.31%

34.32%

-14.01%

Volatility

VST vs. SMMT - Volatility Comparison

The current volatility for Vistra Corp. (VST) is 14.60%, while Summit Therapeutics Inc. (SMMT) has a volatility of 22.47%. This indicates that VST experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VSTSMMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.60%

22.47%

-7.87%

Volatility (6M)

Calculated over the trailing 6-month period

37.50%

56.53%

-19.03%

Volatility (1Y)

Calculated over the trailing 1-year period

48.38%

75.95%

-27.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.87%

185.12%

-137.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.18%

144.63%

-102.45%

Dividends

VST vs. SMMT - Dividend Comparison

VST's dividend yield for the trailing twelve months is around 0.62%, while SMMT has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VST
Vistra Corp.
0.62%0.56%0.63%2.13%3.12%2.64%2.75%2.17%0.00%0.00%14.97%

Financials

VST vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between Vistra Corp. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
5.64B
0
(VST) Total Revenue
(SMMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VST and SMMT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (22.47%) compared to VST (14.60%). In terms of maximum drawdown, VST dropped -53.32% vs SMMT's -95.75%.

VST currently has the higher Sharpe Ratio (-0.31 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VST and SMMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer